Drug Type Monoclonal antibody |
Synonyms- |
Target |
Mechanism SLIT2 inhibitors(slit guidance ligand 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Glomerular disease | Preclinical | CN | 28 Mar 2024 | |
Glomerular disease | Preclinical | SG | 28 Mar 2024 | |
Glomerulosclerosis, Focal Segmental | Preclinical | CN | 28 Mar 2024 | |
Glomerulosclerosis, Focal Segmental | Preclinical | SG | 28 Mar 2024 |